会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • TROPANE-DERIVATIVES, THEIR PREPARATION AND USE
    • TROPANE-DERIVATIVES,他们的准备和使用
    • WO1997030997A1
    • 1997-08-28
    • PCT/EP1997000850
    • 1997-02-21
    • NEUROSEARCH A/SSCHEEL-KRÜGER, JorgenMOLDT, PeterWÄTJEN, Frank
    • NEUROSEARCH A/S
    • C07D451/02
    • C07D451/02C07D451/00
    • The present invention discloses compounds of formula (a), (b), (c) or (d), or any mixture thereof, or a pharmaceutically acceptable salt thereof; wherein R is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl or 2-hydroxyethyl; R is -CH2-X-R', wherein X is O, S or NR", wherein R" is hydrogen, or alkyl and R' is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, or -CO-alkyl; R is phenyl which may be substitued one or more times with substituents selected from the group consisting of halogen, CF3, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl and aryl; 3,4-methylenedioxyphenyl; benzyl which may be substituted one or more times with substituents selected from the group consisting of halogen, CF3, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl and aryl; heteroaryl which may be substitued one or more times with substituents selected from the group consisting of halogen, CF3, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl and aryl; or naphthyl which may be substituted one or more times with substituents selected from the group consisting of halogen, CF3, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl and aryl. The compounds possess valuable pharmaceutical properties as monoamine neurotransmitter, i.e. dopamine, serotonin, noradrenaline, reuptake inhibitors.
    • 本发明公开了式(a),(b),(c)或(d)的化合物或其任何混合物或其药学上可接受的盐; 其中R是氢,烷基,烯基,炔基,环烷基,环烷基烷基或2-羟乙基; R 3是-CH 2 -X-R',其中X是O,S或NR“,其中R”是氢或烷基,R'是烷基,烯基,炔基,环烷基,环烷基烷基或-CO-烷基 ; R 4是可以被选自卤素,CF 3,CN,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基,硝基,杂芳基和芳基的取代基取代一次或多次的苯基; 3,4-亚甲二氧苯基; 可以被选自卤素,CF 3,CN,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基,硝基,杂芳基和芳基的取代基取代一次或多次的苄基。 可以用选自卤素,CF 3,CN,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基,硝基,杂芳基和芳基的取代基取代一次或多次的杂芳基; 或萘基,其可以被选自卤素,CF 3,CN,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基,硝基,杂芳基和芳基的取代基取代一次或多次。 该化合物具有作为单胺神经递质(即多巴胺,5-羟色胺,去甲肾上腺素,再摄取抑制剂)的有价值的药物性质。
    • 8. 发明申请
    • AMPA ANTAGONISTS AND A METHOD OF TREATMENT THEREWITH
    • AMPA拮抗剂及其治疗方法
    • WO1994026747A1
    • 1994-11-24
    • PCT/EP1994001492
    • 1994-05-09
    • NEUROSEARCH A/SWÄTJEN, FrankDREJER, Jorgen
    • NEUROSEARCH A/S
    • C07D487/04
    • C07D471/04C07D487/04
    • The present patent application discloses compounds having formula (I) or a pharmaceutically acceptable salt thereof wherein R is hydrogen, alkyl or benzyl; X is O or NOR , wherein R is hydrogen, alkyl or benzyl; Y is N-R wherein R is hydrogen, OH or alkyl; n is 0 or 1; R is phenyl, naphthyl, thienyl, pyridyl, all of which may be substituted one or more times with substituents selected from the group consisting of halogen; CF3, NO2, amino, alkyl, alkoxy and phenyl; A is a ring of five to seven atoms fused with the benzo ring at the positions marked a and b. The compounds are useful in the treatment of cerebrovascular disorders for example.
    • 本专利申请公开了具有式(I)的化合物或其药学上可接受的盐,其中R 1是氢,烷基或苄基; X是O或NOR 2,其中R 2是氢,烷基或苄基; Y是N-R 4,其中R 4是氢,OH或烷基; n为0或1; R 6是苯基,萘基,噻吩基,吡啶基,它们都可以被选自卤素的取代基取代一次或多次; CF 3,NO 2,氨基,烷基,烷氧基和苯基; A是在标记a和b的位置与苯环稠合的5至7个原子的环。 该化合物可用于治疗例如脑血管障碍。
    • 9. 发明申请
    • 1-PHENYL-BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS BAGA-A RECEPTOR MODULATORS
    • 1-苯基 - 苯并咪唑化合物及其作为BAGA-A受体调节剂的用途
    • WO1998017651A1
    • 1998-04-30
    • PCT/DK1997000462
    • 1997-10-21
    • NEUROSEARCH A/STEUBER, LeneWÄTJEN, Frank
    • NEUROSEARCH A/S
    • C07D235/06
    • C07D235/06C07D401/06C07D401/10C07D401/12C07D401/14C07D405/04C07D413/04
    • The present invention relates to novel benzimidazole compounds, represented by general formula (I) in which o is 0, 1, 2, or 3; R represents an alkyl group, a phenyl group, or a monocyclic heterocyclic group, which groups may be substituted one or more times with substituents selected from alkyl, cycloalkyl, cycloalkyl-alkyl, alkoxy, halogen, trifluoromethyl, cyano, amino, and nitro; or R represents a cyano group or a group of the formula -alkyl-CO2R , alkenyl-CO2R , -CO-R , -CO2(CH2)mR , or -C(R )=N-OR , R represents a group of formula -CO2-R , or R represents a group of general formula (II) in which n is 0, 1, 2 or 3; or R may represent a group of general formula (III), in which n is 0, 1, 2, or 3; the novel compounds of the invention are useful in the treatment of central nervous system diseases and disorders, which are responsive to modulation of the GABAA receptor complex, such as for example anxiety, sleep disorders, anaestesia, memory disorders, and epilepsia or other convulsive disorders.
    • 本发明涉及由通式(I)表示的新的苯并咪唑化合物,其中o为0,1,2或3; R 1表示烷基,苯基或单环杂环基,该基团可以被选自烷基,环烷基,环烷基 - 烷基,烷氧基,卤素,三氟甲基,氰基,氨基, 和硝基; 或R 1表示氰基或式 - 烷基-CO 2 R 2,烯基-CO 2 R 2,-CO-R 2,-CO 2(CH 2)m R 2或 - C(R 3)= N-OR 2,R 11表示式-CO 2 -R 9的基团,或R 11表示通式(II)的基团,其中n为 0,1,2或3; 或R 11可以表示通式(III)的基团,其中n为0,1,2或3; 本发明的新化合物可用于治疗对GABA A受体复合物的调节有反应的中枢神经系统疾病和病症,例如焦虑症,睡眠障碍,麻醉,记忆障碍和癫痫或其它惊厥性疾病 。
    • 10. 发明申请
    • NOVEL INDOLE-2,3-DIONE-3-OXIME DERIVATIVES
    • 新型吲哚-3,3-二酮-3-氧化物衍生物
    • WO1998014447A1
    • 1998-04-09
    • PCT/DK1997000418
    • 1997-10-01
    • NEUROSEARCH A/SWÄTJEN, FrankDREJER, Jorgen
    • NEUROSEARCH A/S
    • C07D471/04
    • C07D471/04C07D487/04
    • The present invention relates to novel indole-2,3-dione-3-oxime derivatives capable of antagonising the effect of excitatory amino acids, such as glutamate. More specifically the novel indole-2,3-dione-3-oxime derivatives of the invention may be described by general formula (I), wherein R represents "Het", or a group of formula (II), wherein "Het" represents a saturated or unsaturated, 4 to 7 membered, monocyclic, heterocyclic ring, at least one of R , R , and R independently represents hydrogen, alkyl, or hydroxyalkyl, and at least one of R , R , and R independently represents (CH2)nR ; wherein R represents hydroxy, carboxy, alkoxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, cycloalkoxycarbonyl, cycloalkyl-alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, CONR R , or "Het"; wherein n is 0, 1, 2, or 3; and R represents phenyl, naphthyl, thienyl, or pyridyl, all of which may be substituted. "A" represents a ring of five to seven atoms fused with the benzo ring at the positions marked "a" and "b", and formed by the following bivalent radicals: a-NR -CH2-CH2-b; a-CH2-NR -CH2-b; a-CH2-CH2-NR -b; a-NR -CH2-CH2-CH2-b; a-CH2-NR -CH2-CH2-b; a-CH2-CH2-NR -CH2-b; a-CH2-CH2-CH2-NR -b; a-NR -CH2-CH2-CH2-CH2-b; a-CH2-NR -CH2-CH2-CH2-b; a-CH2-CH2-NR -CH2-CH2-b; a-CH2-CH2-CH2-NR -CH2-b; or a-CH2-CH2-CH2-CH2-NR -b; wherein R represents hydrogen, alkyl or CH2CH2OH; or a pharmaceutically acceptable salt thereof.
    • 本发明涉及能够拮抗兴奋性氨基酸如谷氨酸的作用的新的吲哚-2,3-二酮-3-肟衍生物。 更具体地,本发明的新的吲哚-2,3-二酮-3-肟衍生物可以由通式(I)描述,其中R 3表示“Het”,或式(II)的基团,其中“ Het“表示饱和或不饱和的4至7元单环杂环,R 31,R 32和R 33中的至少一个独立地表示氢,烷基或羟烷基,并且至少一个 R 31,R 32和R 33独立地表示(CH 2)n R 34; 其中R 34表示羟基,羧基,烷氧基羰基,烯氧基羰基,炔氧基羰基,环烷氧基羰基,环烷基 - 烷氧基羰基,芳氧基羰基,芳烷氧羰基,CONR 35 R 36或“Het”。 其中n为0,1,2或3; 并且R 5代表苯基,萘基,噻吩基或吡啶基,它们都可被取代。 “A”表示在标记为“a”和“b”的位置与苯并环稠合的5至7个原子的环,由以下二价基团形成:a-NR 6 -CH 2 -CH 2 -B; 一个-CH2-NR <6> -CH2-B; 一个-CH2-CH2-NR <6> -b; 一个-NR <6> -CH2-CH2-CH2-B; 一个-CH2-NR <6> -CH2-CH2-B; 一个-CH2-CH2-NR <6> -CH2-B; 一个-CH2-CH2-CH2-NR <6> -b; 一个-NR <6> -CH2-CH2-CH2-CH2-B; 一个-CH2-NR <6> -CH2-CH2-CH2-B; 一个-CH2-CH2-NR <6> -CH2-CH2-B; 一个-CH2-CH2-CH2-NR <6> -CH2-B; 或a-CH2-CH2-CH2-CH2-NR6-b; 其中R 6表示氢,烷基或CH 2 CH 2 OH; 或其药学上可接受的盐。